Health In Tech, Inc. (HIT)
| Market Cap | 64.22M -58.9% |
| Revenue (ttm) | 32.83M +23.0% |
| Net Income | -3.95M |
| EPS | -0.07 |
| Shares Out | 65.53M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 64,934 |
| Open | 0.9810 |
| Previous Close | 1.0000 |
| Day's Range | 0.9710 - 1.0200 |
| 52-Week Range | 0.8501 - 4.0200 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 3.70 (+277.55%) |
| Earnings Date | Aug 13, 2026 |
About HIT
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to qu... [Read more]
Financial Performance
In 2025, Health In Tech's revenue was $33.33 million, an increase of 70.99% compared to the previous year's $19.49 million. Earnings were $1.28 million, an increase of 90.74%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for HIT stock is "Buy." The 12-month stock price target is $3.7, which is an increase of 277.55% from the latest price.
News
Health In Tech reports Q2 EPS (4c), consensus (3c)
Reports Q2 revenue $8.1MM, consensus $7.78M. CEO Tim Johnson commented, “We continued to execute against our long-term growth strategy during the quarter by investing in sales, marketing, and key tale...
Health In Tech still sees 2026 revenue $45M-$50M, consensus $46.81M
16:34 EDT Health In Tech (HIT) still sees 2026 revenue $45M-$50M, consensus $46.81M
Health In Tech price target lowered to $3 from $4 at Maxim
Maxim lowered the firm’s price target on Health In Tech (HIT) to $3 from $4 and keeps a Buy rating on the shares. The firm is updating its model after…
Health In Tech Earnings Call Transcript: Q2 2026
Q2 revenue declined due to timing shifts from new carrier onboarding, but contracted and pipeline revenue remain strong, supporting reaffirmed 2026 guidance of $45–$50 million. Platform upgrades, new product launches, and anticipated A-rated carrier partnerships are expected to drive future growth.
Health In Tech Earnings release: Q2 2026
Health In Tech released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Health In Tech Quarterly report: Q2 2026
Health In Tech has published its Q2 2026 quarterly earnings report on August 13, 2026.
Health In Tech Slides: Q2 2026
Health In Tech has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
Health In Tech Reports Second Quarter 2026 Financial Results
Contracted Revenue of $32.3 Million as of June 30, 2026 Pipeline Revenue of $66.3 Million as of July 31, 2026 Distribution Partners Grew 19.9% Year Over Year STUART, Fla., Aug. 13, 2026 /PRNewswire/ -...
Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026
STUART, Fla., Aug. 3, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the second quarter e...
Health In Tech added as member of Russell Microcap Index
Health In Tech (HIT) was added as a member of the Russell Microcap Index, effective when the U.S. market opens on June 29, as part of the 2026 Russell U.S.
Health In Tech Added to Membership of Russell Microcap® Index
STUART, Fla., June 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") was added as a member of the Russell Microcap® Index, effective when the U.S. market ...
Health In Tech Registration statement: Registration filing
Health In Tech filed a registration statement on June 26, 2026, providing details about a securities offering with the SEC.
Health In Tech files $300M mixed securities shelf
12:24 EDT Health In Tech (HIT) files $300M mixed securities shelf
Health In Tech Registration statement: Registration filing
Health In Tech filed a registration statement on June 10, 2026, providing details about a securities offering with the SEC.
Health In Tech Registration statement: Registration filing
Health In Tech filed a registration statement on May 22, 2026, providing details about a securities offering with the SEC.
Health In Tech Earnings Call Transcript: Q1 2026
Q1 2026 revenue grew 9% to $8.8M, with a net loss of $1.6M as investments in sales, tech, and distribution accelerated. Full-year revenue guidance of $45–$50M was reiterated, and new platform features and products are driving positive broker feedback and future growth.
Health In Tech Slides: Q1 2026
Health In Tech has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 13, 2026.
Health In Tech Earnings release: Q1 2026
Health In Tech released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
Health In Tech Quarterly report: Q1 2026
Health In Tech has published its Q1 2026 quarterly earnings report on May 13, 2026.
Health In Tech reports Q1 EPS (3c), consensus (2c)
Reports Q1 revenue $8.8M, consensus $7.46M. Tim Johnson, Chief Executive Officer of Health In Tech (HIT), commented, “In the first quarter of 2026, we continued to execute on strategic priorities…
Health In Tech backs FY26 revenue view $45M-$50M, consensus $46.36M
Health In Tech (HIT) reiterated guidance for 2026 annual revenue ranging between $45M-$50M, representing year-over-year growth of approximately 35% to 50%. As of March 31, 2026, the company’s contract...
Health In Tech Reports First Quarter 2026 Financial Results
Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 Million STUART, Fla., May 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), a...
Health In Tech to Announce First Quarter 2026 Financial Results on May 13, 2026
STUART, Fla., April 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the first quarter ...
Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)
FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HIT Phase 2 data showed a greater than 25% absolute reduction in thrombotic events when CAD-1005 was added to stand...
Health In Tech files to sell 5.6M shares of Class A common stock for holders
17:08 EDT Health In Tech (HIT) files to sell 5.6M shares of Class A common stock for holders